CS175500B2 - - Google Patents

Info

Publication number
CS175500B2
CS175500B2 CS215A CS21576A CS175500B2 CS 175500 B2 CS175500 B2 CS 175500B2 CS 215 A CS215 A CS 215A CS 21576 A CS21576 A CS 21576A CS 175500 B2 CS175500 B2 CS 175500B2
Authority
CS
Czechoslovakia
Application number
CS215A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS175500B2 publication Critical patent/CS175500B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CS215A 1974-08-05 1975-07-22 CS175500B2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CS175500B2 true CS175500B2 (de) 1977-05-31

Family

ID=5922668

Family Applications (2)

Application Number Title Priority Date Filing Date
CS215A CS175500B2 (de) 1974-08-05 1975-07-22
CS5170A CS175498B2 (de) 1974-08-05 1975-07-22

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS5170A CS175498B2 (de) 1974-08-05 1975-07-22

Country Status (17)

Country Link
US (1) US4029777A (de)
JP (1) JPS5141347A (de)
AT (1) AT345998B (de)
BE (1) BE832124A (de)
CA (1) CA1037027A (de)
CH (1) CH611910A5 (de)
CS (2) CS175500B2 (de)
DD (1) DD120192A5 (de)
DE (1) DE2438020A1 (de)
DK (1) DK136369C (de)
ES (1) ES439720A1 (de)
FR (1) FR2281123A1 (de)
GB (1) GB1512258A (de)
HU (1) HU171684B (de)
IL (1) IL47770A (de)
NL (1) NL7509326A (de)
SE (1) SE404804B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
EP3868382A1 (de) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Neuroaktive steroide, zusammensetzungen und verwendungen davon
SI3488852T1 (sl) 2013-08-23 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SG11201703073UA (en) 2014-10-16 2017-05-30 Sage Therapeutics Inc Compositions and methods for treating cns disorders
PT3206493T (pt) 2014-10-16 2020-08-03 Sage Therapeutics Inc Composições e métodos para tratamento de transtornos do snc
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
EP3481844B1 (de) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C12-substituierte neuroaktive steroide und deren verfahren zur verwendung
MX2020006599A (es) * 2017-12-22 2020-11-06 Sage Therapeutics Inc Composiciones y metodos para el tratamiento de trastornos en el sistema nervioso central.
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
DK136369B (da) 1977-10-03
FR2281123A1 (fr) 1976-03-05
ES439720A1 (es) 1977-03-01
AT345998B (de) 1978-10-10
IL47770A (en) 1978-10-31
DD120192A5 (de) 1976-06-05
JPS5141347A (en) 1976-04-07
GB1512258A (en) 1978-05-24
ATA600475A (de) 1978-02-15
NL7509326A (nl) 1976-02-09
DE2438020A1 (de) 1976-02-26
IL47770A0 (en) 1975-10-15
BE832124A (fr) 1976-02-05
SE404804B (sv) 1978-10-30
AU8351575A (en) 1977-02-03
US4029777A (en) 1977-06-14
CH611910A5 (de) 1979-06-29
SE7508777L (sv) 1976-02-06
CA1037027A (en) 1978-08-22
CS175498B2 (de) 1977-05-31
HU171684B (hu) 1978-02-28
DK344475A (da) 1976-02-06
DK136369C (da) 1978-02-27

Similar Documents

Publication Publication Date Title
DK138858C (de)
FI750550A7 (de)
FI750417A7 (de)
DK691874A (de)
FR2257188A1 (de)
DK52775A (de)
DK142816C (de)
FR2256570A1 (de)
DK113675A (de)
FR2257226A1 (de)
CS175852B1 (de)
CS166589B1 (de)
FR2256949A1 (de)
CS164720B1 (de)
CS164726B1 (de)
CS165264B1 (de)
DK10275A (de)
CS169568B1 (de)
CS172032B1 (de)
DD120192A5 (de)
DD116665A1 (de)
DD109331A1 (de)
DD110378A1 (de)
DD110666A1 (de)
CH593351A5 (de)